Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STRIDES PHARMA SCIENCE LIMITED Share Issue/Capital Change 2023

Oct 20, 2023

62616_rns_2023-10-20_f57c0aa5-60fa-4c99-adab-6b6a1d65b0fe.pdf

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

==> picture [154 x 50] intentionally omitted <==

October 20, 2023

BSE Limited

Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400 001 Scrip code: 532531

The National Stock Exchange of India Limited Exchange Plaza, Bandra-Kurla Complex Bandra (E) Mumbai - 400 051

Scrip code: STAR

Dear Sirs,

Sub: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. SEBI/ HO/ CFD/ CFD-PoD-1/ P/ CIR/ 2023/ 123 dated July 13, 2023

This is to inform you that Management Committee of the Board of Directors of the Company in their meeting held today have allotted 3,50,000 equity shares of face value of Rs. 10/- each to M/s. Karuna Business Solutions LLP (Warrant Holder) upon conversion of equivalent number of warrants to equity shares. These shares shall rank in pari passu with the existing equity shares of the Company in all respects.

Consequent to above, paid-up share capital of the Company has increased from Rs. 90,33,28,540 consisting of 9,03,32,854 equity shares of Rs. 10/- each to Rs. 90,68,28,540 consisting of 9,06,82,854 equity shares of Rs. 10/- each.

Disclosure under Regulation 30 of SEBI Listing Regulations read with SEBI circular dated September 9, 2015, bearing reference no. CIR/CFD/CMD/4/2015 ("SEBI Circular’), read with SEBI Circular No. SEBI/HO/CFD/CFD-PoD1/P/CIR/2023/123 dated July 13, 2023 are provided in ‘ Annexure 1’.

Request you to take the above on record.

Thanks & Regards,

For Strides Pharma Science Limited,

==> picture [90 x 87] intentionally omitted <==

MANJULA Digitally signed by MANJULA RAMAMUR RAMAMURTHY Date: 2023.10.20 THY 18:10:56 +05'30' Manjula Ramamurthy Company Secretary ICSI Membership No.: A30515

Encl: As above

==> picture [506 x 48] intentionally omitted <==

==> picture [154 x 50] intentionally omitted <==

Annexure 1

Disclosure under Regulation 30 read with Schedule III to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI LODR) and SEBI Circular bearing reference SEBI/ HO/ CFD/ CFD‐PoD‐1/ P/ CIR/ 2023/ 123 dated July 13, 2023

# Particulars Particulars Details Details Details Details Details
1. Type of securities proposed tobe issued Equity Shares pursuant to conversion of Warrants
2. Type of issuance Preferential allotment
3. Total number of securitiesproposed to be issued or thetotal amount for which thesecurities will be issued(approximately) Allotment of 3,50,000 Equity Shares of face value of Rs.10/‐ each upon conversion of equal number of Warrants atan issue price of Rs. 442/‐ each (inclusive of a premium ofRs. 432/- per share).
4. Additional information i n case of Preferent ial Issue
i. Names of the Investors Karuna Bu siness Solutions LLP
ii. Post allotment of securitie s
Ot f th b ti Alltt f 350000 Eit S f f l f R
a. ucome o e suscrissue price/ allotted price pon, omen10/‐ each u o ,, quypon conversion of eq ares o ace vaue oual number of Warra s.nts atm of
(in case of convertibles) an issue prRs. 432/- p ice of Rs. 442/‐ each (er share). inclusive of a premiu
b Number of investors One
c. In case of convertibles –intimation on conversion ofsecurities or on lapse of thetenure of the instruments Allotment of 3,50,000 equity shares of face value of Rs. 10/‐per share of the Company upon exercise of 3,50,000warrants.

==> picture [506 x 48] intentionally omitted <==